Mediplantex National Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -24.61% vs 34.97% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -3.47% vs 56.99% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "88,664.20",
          "val2": "117,611.90",
          "chgp": "-24.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10,057.10",
          "val2": "8,426.20",
          "chgp": "19.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,096.70",
          "val2": "1,296.60",
          "chgp": "-15.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,926.30",
          "val2": "6,139.30",
          "chgp": "-3.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "94.70%",
          "val2": "71.60%",
          "chgp": "2.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -17.16% vs 10.03% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.16% vs 29.83% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "367,081.40",
          "val2": "443,135.80",
          "chgp": "-17.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28,191.90",
          "val2": "30,109.10",
          "chgp": "-6.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2,310.50",
          "val2": "3,787.30",
          "chgp": "-38.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15,271.70",
          "val2": "15,246.80",
          "chgp": "0.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "57.50%",
          "val2": "50.10%",
          "chgp": "0.74%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

88,664.20

117,611.90

-24.61%

Operating Profit (PBDIT) excl Other Income

10,057.10

8,426.20

19.36%

Interest

1,096.70

1,296.60

-15.42%

Exceptional Items

0.00

0.00

Consolidate Net Profit

5,926.30

6,139.30

-3.47%

Operating Profit Margin (Excl OI)

94.70%

71.60%

2.31%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -24.61% vs 34.97% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -3.47% vs 56.99% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

367,081.40

443,135.80

-17.16%

Operating Profit (PBDIT) excl Other Income

28,191.90

30,109.10

-6.37%

Interest

2,310.50

3,787.30

-38.99%

Exceptional Items

0.00

0.00

Consolidate Net Profit

15,271.70

15,246.80

0.16%

Operating Profit Margin (Excl OI)

57.50%

50.10%

0.74%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -17.16% vs 10.03% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 0.16% vs 29.83% in Dec 2024

All Annual Results